Background and Purpose—Statins reduce infarct size in animal models of stroke and have
been hypothesized to improve clinical outcomes after ischemic stroke. We examined the …

Abstract Background Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors)
have neuroprotective effects in experimental stroke models and are commonly prescribed in …

Background and Purpose—The majority of patients with previous ischemic stroke are
expected to benefit significantly from long-term statin therapy. However, discontinuation of …

Background and Purpose—Statins improve infarct volume and neurological outcome in
animal stroke models. We investigated the relationship between statin therapy and ischemic …

Background—In patients with ischemic stroke, data on the real-world effectiveness of statin
therapy for clinical and patient-centered outcomes are needed to better inform shared …

Background and Purpose—Statins reduce the risk of stroke in at-risk populations and may
improve outcomes in patients taking statins before an ischemic stroke (IS). Our objectives …

In addition to their lipid‐lowering effects, it has been speculated that statins may also have
beneficial effects on cerebral circulation and brain parenchyma during ischaemic stroke and …

Background: Statin treatment is effective at preventing adverse vascular events after
ischemic stroke (IS). However, many patients fail to use statins after IS. We studied the …

Background and Purpose—Statin is an established treatment for secondary prevention after
ischemic stroke. However, the effects of statin intensity and adherence on the long-term …

Objective: To determine whether statin therapy after hospital discharge affects ischemic
stroke recurrence and long-term mortality in patients admitted for a first-ever occurrence of …